Pfizer

PFE • NYSE •
Overview Stats Financials News

Quarterly Financials

Values in thousands 2024-03-31 2023-12-31 2023-09-30 2023-06-30
Revenue $14,879,000 $14,249,000 $13,232,000 $12,734,000
Gross Profit 10,498,000 5,657,000 2,629,000 9,497,000
EBITDA 6,295,000 77,000 -1,705,000 4,210,000
EBIT 4,559,000 -1,593,000 -3,265,000 3,026,000
Net Income 3,115,000 -3,344,000 -2,394,000 2,327,000
Net Change In Cash 14,879,000 14,249,000 13,232,000 12,734,000
Cost of Revenue 481,000
Free Cash Flow 387,000 4,196,000 2,646,000 -2,122,000
Cash 719,000 2,853,000 3,148,000 2,632,000
Basic Shares 5,697,000 5,647,000 5,646,000 5,713,000

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue $58,496,000 $100,330,000 $81,288,000 $41,908,000
Gross Profit 29,283,000 65,986,000 50,467,000 33,216,000
EBITDA 10,525,000 43,639,000 28,533,000 14,066,000
EBIT 4,235,000 40,030,000 24,833,000 10,630,000
Net Income 2,119,000 31,372,000 21,979,000 7,020,000
Net Change In Cash 58,496,000 100,330,000 81,288,000 41,908,000
Cost of Revenue -1,350,000 218,000 483,000
Free Cash Flow 4,793,000 26,031,000 29,869,000 11,612,000
Cash 2,853,000 416,000 1,944,000 1,784,000
Basic Shares 5,709,000 5,733,000 5,708,000 5,632,000

Earnings Calls

Quarter EPS
2024-03-31 $0.82
2023-12-31 $0.10
2023-09-30 -$0.17
2023-06-30 $0.67